Trial Profile
Intralesional Ranibizumab on Pterygium Vascularity, Size and Recurrence Rate: a Pilot Study
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 27 Apr 2020
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Pterygium
- Focus Therapeutic Use
- 23 Jan 2015 New trial record